{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T04:08:55Z","timestamp":1770437335963,"version":"3.49.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/wnf.0b013e318203d415","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T13:09:44Z","timestamp":1294232984000},"page":"1-4","source":"Crossref","is-referenced-by-count":22,"title":["Long-Term Follow-Up of Patients With Narcolepsy-Cataplexy Treated With Sodium Oxybate (Xyrem)"],"prefix":"10.1097","volume":"34","author":[{"given":"Mashael K.","family":"Alshaikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divine","family":"Gacuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smitha","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munir","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"BaHammam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"9560","key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy.","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"R2-1-20210203","first-page":"1352","article-title":"Narcolepsy in Saudi Arabia. Demographic and clinical perspective of an under-recognized disorder.","volume":"27","author":"BaHammam","year":"2006","journal-title":"Saudi Med J"},{"issue":"2","key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/sleep\/25.2.197","article-title":"The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study.","volume":"25","author":"Silber","year":"2002","journal-title":"Sleep"},{"issue":"1","key":"R4-1-20210203","first-page":"42","article-title":"S. Xyrema Multicenter Study Group. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.","volume":"25","author":"The","year":"2002","journal-title":"Sleep"},{"issue":"3","key":"R5-1-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1358\/dot.2008.44.3.1162240","article-title":"Sodium oxybate: efficacy, safety and tolerability in the treatment of narcolepsy with or without cataplexy.","volume":"44","author":"Owen","year":"2008","journal-title":"Drugs Today (Barc)"},{"issue":"3","key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3810\/pgm.2009.05.2008","article-title":"Narcolepsy-master of disguise: evidence-based recommendations for management.","volume":"121","author":"Mohsenin","year":"2009","journal-title":"Postgrad Med"},{"issue":"4","key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5664\/jcsm.27549","article-title":"Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion.","volume":"5","author":"Wang","year":"2009","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.sleep.2009.01.005","article-title":"Three deaths associated with use of Xyrem.","volume":"10","author":"Zvosec","year":"2009","journal-title":"Sleep Med"},{"issue":"2","key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/sleep\/15.2.173","article-title":"EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association.","volume":"15","year":"1992","journal-title":"Sleep"},{"issue":"3","key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/sleep\/15.3.268","article-title":"The clinical use of the Multiple Sleep Latency Test. The Standards of Practice Committee of the American Sleep Disorders Association.","volume":"15","author":"Thorpy","year":"1992","journal-title":"Sleep"},{"issue":"6","key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale.","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"issue":"1","key":"R14-1-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pediatrneurol.2009.02.008","article-title":"Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.","volume":"41","author":"Huang","year":"2009","journal-title":"Pediatr Neurol"},{"issue":"8","key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/sleep\/29.8.1025","article-title":"Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate.","volume":"29","author":"Murali","year":"2006","journal-title":"Sleep"},{"issue":"10","key":"R16-1-20210203","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archneur.65.10.1337","article-title":"Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study.","volume":"65","author":"Ondo","year":"2008","journal-title":"Arch Neurol"},{"issue":"7","key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1197\/aemj.9.7.730","article-title":"2nd. Gamma hydroxybutyric acid (GHB) intoxication.","volume":"9","author":"Mason","year":"2002","journal-title":"Acad Emerg Med"},{"issue":"1","key":"R18-1-20210203","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.sleep.2009.02.009","article-title":"Obstructive sleep apnea in narcolepsy.","volume":"11","author":"Sansa","year":"2010","journal-title":"Sleep Med"},{"issue":"1","key":"R19-1-20210203","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.sleep.2007.11.018","article-title":"Increase in sleep-related breathing disturbances after treatment with sodium oxybate in patients with narcolepsy and mild obstructive sleep apnea syndrome: two case reports.","volume":"10","author":"Seeck-Hirschner","year":"2009","journal-title":"Sleep Med"},{"issue":"1","key":"R20-1-20210203","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.sleep.2009.06.006","article-title":"A safety trial of sodium oxybate in patients with obstructive sleep apnea: acute effects on sleep-disordered breathing.","volume":"11","author":"George","year":"2010","journal-title":"Sleep Med"},{"issue":"5","key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.sleep.2005.03.010","article-title":"Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.","volume":"6","year":"2005","journal-title":"Sleep Med"},{"issue":"4","key":"R23-1-20210203","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5664\/jcsm.26368","article-title":"A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.","volume":"1","year":"2005","journal-title":"J Clin Sleep Med"},{"issue":"9211","key":"R24-1-20210203","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(05)74704-8","article-title":"Increased body-mass index in patients with narcolepsy.","volume":"355","author":"Schuld","year":"2000","journal-title":"Lancet"},{"issue":"6","key":"R25-1-20210203","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.sleep.2008.05.012","article-title":"Weight loss in narcolepsy patients treated with sodium oxybate.","volume":"10","author":"Husain","year":"2009","journal-title":"Sleep Med"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002826-201101000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:52:12Z","timestamp":1618278732000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002826-201101000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e318203d415","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}